Prostate Cancer

Cancer is commonly defined as the uncontrolled division of abnormal cells. When cells become aged or damaged, they are replaced with new cells. Sometimes the genetic material (DNA) of a cell can become damaged or altered, producing mutations that negatively affect cell growth and division. Prostate cancer may be slow growing, or it may be aggressive. When confined within the prostate or another organ, cancer is known to be “localized” or “organ-confined”. When cancer cells spread throughout the body (metastasize) via blood and lymph systems, they can become life threatening.

Prostate cancer is one of the leading forms of cancer diagnosed in North American men, typically in men over the age of 50. In its early stages, prostate cancer has no symptoms, which is why it’s important for men to have regular medical checkups. If diagnosed early, prostate cancer is often curable. Treatment can eliminate symptoms and prolong life expectancy.

Prostate_Cancer_pic

Risk Factors

There are several risk factors for prostate cancer, some modifiable, others not. These include:

  • Age – Prostate cancer is most commonly diagnosed in men over the age of 50.
  • Family History – Research shows an increased risk for prostate cancer in sons, brothers and fathers of men with the disease.
  • Genetics – Inherited gene changes may increase prostate cancer risk.
  • Diet – High fat, high calcium and high red meat diets may increase the risk of developing prostate cancer.
  • Ethnicity – Studies have shown that prostate cancer is more common in men of African ethnicity.

For more information about the prostate, visit the Prostate Cancer Canada website.

Falling Walls Venture – Berlin 2018

Congratulations to John Lewis and Nanostics for winning an entry into the highly competitive and prestigious Falling Walls Venture Conference in Berlin, November 8-9, 2018!

Five presenters pitched their healthcare-related ideas and innovations to a panel of tech and business-savvy judges and a large audience on Aug 29, 2018, at the University of Alberta in a high-stakes “TEDTalk” meets “Dragon’s Den” style. The competition was tough but John Lewis edged out the fellow contenders to win a chance to pitch a 5-minute talk on Nanostics’ high-accuracy prostate cancer diagnostic reflex test: ClarityDX Prostate.

John talked with Mark Connolly from the CBC Edmonton Morning show on September 4 about the Falling Walls competition and what he is preparing for this November.

Good luck to John Lewis at the Falling Walls Finale in Berlin!

John Lewis wins an entry to Falling Walls Berlin!

- Perrin Beatty